Patents by Inventor Ed Kisak

Ed Kisak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20200237919
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: September 18, 2019
    Publication date: July 30, 2020
    Inventors: Ed KISAK, Jagat SINGH
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20170266296
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: December 5, 2016
    Publication date: September 21, 2017
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9539335
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: January 10, 2017
    Assignee: HZNP Limited
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20160213784
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: April 6, 2016
    Publication date: July 28, 2016
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9339551
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: May 17, 2016
    Assignee: HZNP Limited
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9339552
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: May 17, 2016
    Assignee: HZNP Limited
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20160045605
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: October 26, 2015
    Publication date: February 18, 2016
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9220784
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: December 29, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20150313998
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: May 6, 2015
    Publication date: November 5, 2015
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9168305
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: October 27, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9168304
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: October 27, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20150231263
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: May 6, 2015
    Publication date: August 20, 2015
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20150231264
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: May 6, 2015
    Publication date: August 20, 2015
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20150231262
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: May 6, 2015
    Publication date: August 20, 2015
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9101591
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: January 14, 2015
    Date of Patent: August 11, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • Diclofenac topical formulation
    Patent number: 9066913
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: June 30, 2015
    Assignee: HZNP LIMITED
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20150126606
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: January 14, 2015
    Publication date: May 7, 2015
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20150126607
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: January 14, 2015
    Publication date: May 7, 2015
    Inventors: Ed Kisak, Jagat Singh
  • DICLOFENAC TOPICAL FORMULATION
    Publication number: 20150011635
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Application
    Filed: September 25, 2014
    Publication date: January 8, 2015
    Inventors: Ed Kisak, JAGAT SINGH
  • Diclofenac topical formulation
    Patent number: 8871809
    Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: October 28, 2014
    Assignee: Nuvo Research Inc.
    Inventors: Ed Kisak, Jagat Singh